Impact of Chronic Obstructive Pulmonary Disease on Valve Academic Research Consortium–Defined Outcomes After Transcatheter Aortic Valve Implantation (from the FRANCE 2 Registry)

2014 ◽  
Vol 113 (9) ◽  
pp. 1543-1549 ◽  
Author(s):  
Romain Chopard ◽  
Nicolas Meneveau ◽  
Sidney Chocron ◽  
Martine Gilard ◽  
Marc Laskar ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Aortic Valve ◽  
Pulmonary Disease ◽  
Academic Research ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Transcatheter Aortic Valve ◽  
Aortic Valve Implantation ◽  
Research Consortium ◽  
Valve Implantation

Incidence and Risk Factors for Infection Following Transcatheter Aortic Valve Implantation

2016 ◽  
Vol 37 (9) ◽  
pp. 1094-1097 ◽  
Author(s):  
Yuhao Shi ◽  
Harindra C. Wijeysundera ◽  
Stephen E. Fremes ◽  
Andrew E. Simor
Keyword(s):  
Risk Factors ◽  
Chronic Obstructive Pulmonary Disease ◽  
Aortic Valve ◽  
Pulmonary Disease ◽  
Transcatheter Aortic Valve Implantation ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Transcatheter Aortic Valve ◽  
Aortic Valve Implantation ◽  
Valve Implantation

We identified risk factors for infection following transcatheter aortic valve implantation (TAVI); infection occurred in 35 (13.8%) of 253 patients. Variables associated with infection included chronic obstructive pulmonary disease (OR, 1.2; 95% CI, 1.1–1.4), postprocedural hemorrhage (OR, 1.2; 95% CI, 1.0–1.3), and procedure-related stroke (OR, 1.6; 95% CI, 1.3–2.1).Infect Control Hosp Epidemiol 2016;37:1094–1097

Sign in / Sign up

Export Citation Format

Share Document